CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 12,173	$ 30,718
General and administrative	10,662	12,513
Restructuring costs	9,464
Total operating expenses	32,299	43,231
Loss from operations	(32,299)	(43,231)
Total other income (loss), net:
Interest income	1,246	1,325
Other income (loss), net	754	723
Net loss	$ (30,299)	$ (41,183)
Net loss per share - basic	$ (0.26)	$ (0.44)
Net loss per share - diluted	$ (0.26)	$ (0.44)
Weighted-average common shares outstanding - basic	114,690,726	93,303,672
Weighted-average common shares outstanding - diluted	114,690,726	93,303,672
Comprehensive loss:
Net Income (Loss)	$ (30,299)	$ (41,183)
Other comprehensive income (loss), net of tax:
Unrealized (loss) gain on available-for-sale securities	(76)	167
Total other comprehensive income (loss)	(76)	167
Comprehensive loss	$ (30,375)	$ (41,016)